SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-024686
Filing Date
2024-10-03
Accepted
2024-10-03 19:17:34
Documents
1
Period of Report
2024-10-01

Document Format Files

Seq Description Document Type Size
1 form4-10032024_111030.html 4  
1 form4-10032024_111030.xml 4 6701
  Complete submission text file 0001415889-24-024686.txt   8241
Mailing Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011 (425) 620-8501
Athira Pharma, Inc. (Issuer) CIK: 0001620463 (see all company filings)

IRS No.: 453368487 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O ATHIRA PHARMA, INC. 18706 NORTH CREEK PARKWAY, SUITE 104 BOTHELL WA 98011
Business Address
Renninger Robert (Reporting) CIK: 0002037968 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39503 | Film No.: 241353151